TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT04688658

Duvelisib in Combination With Nivolumab in Patients With Advanced Unresectable Melanoma

Cause of deathFunding or business Automatic label, confidence 0.5, unverified. How labels are made.
“Secura Bio, Inc. discontinued support of the trial.”

The sponsor’s own words in the registry.

Life of this trial

2020202120222023202420252026Registered2020-12-23Started2021-10-06Primary completion2024-02-22Stopped2025-02-01Results posted2025-12-17

Vital statistics

Status
Terminated
Phase
Phase 1, Phase 2
Sponsor
John Kirkwood
Sponsor type
University, hospital or other
Conditions
Unresectable Melanoma
Interventions
Nivolumab; Duvelisib
Participants
13
Sites
1
Countries
United States

Trials that died the same way

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.